Robert Motzer

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  

Robert Motzer
Dec 20, 2024, 14:04 | Science
Elvina Almuradova: JAVELIN Renal 101 Phase 3 Trial Results by Toni Choueiri et al.
A recent paper by Toni Choueiri, Director of the Lank Center for Genitourinary Oncology at…
Nov 8, 2024, 18:55 | Insight
Regina Barragan-Carrillo: First and second - line treatments in metastatic renal cell carcinoma
Regina Barragan-Carrillo, Postdoctoral fellow at the Genitourinary Clinic at the Medical Oncology and Medical Therapeutics…
Jul 13, 2024, 12:22 | Insight
Key Highlights from KCRS24 by Sumanta K. Pal
Kidney Cancer Research Summit or the KCRS24 was a conference held on 11th-12th July in Boston focused…
Jun 10, 2024, 15:00 | Blog
Sumanta K. Pal: PIVOT09 comparing pegylated IL2/nivolumab to TKI by Nizar Tannir et al.
Sumanta K. Pal shared a post on X: “Huge congrats to Nizar Tannir, MD Anderson Cancer…
May 28, 2024, 07:49 | Insight
Tom Powles: Renal cancer highlights at ASCO24 - KIM1 biomarker data stands out
Toni Choueiri shared a post by Tom Powles, Director of Barts Cancer Center, on X and…
Apr 20, 2024, 06:03 | Insight
Toni Choueiri: The long-awaited OS results from KEYNOTE-564 are out at the New England Journal of Medicine!
Toni Choueiri shared on X/Twitter: "The long-awaited OS results from KEYNOTE-564 are out at the New…
Feb 24, 2024, 16:50 | Blog
Toni Choueiri: New insights from the JAVELIN Renal 101 trial in RCC in Cancer Discovery
Toni Choueiri, Professor of Medicine at Harvard Medical School and Director of the Lank Center for…
Jan 27, 2024, 17:17 | Societies
ASCO GU 2024 – New insights in clear cell renal cancer (RCC) – Adjuvant perspectives
By Marcos Franca During the morning in ASCO GU 2024 meeting, in San Francisco –…
All: 8 Posts: 1 - 100
Special Coverage